Objective: Uncoupling protein 2 (UCP2) plays a crucial role in energy homeostasis via regulation of insulin secretion, free fatty acid concentrations, and lipid metabolism. This study aimed to investigate the association of 45-bp ins/del polymorphism of UCP2 with susceptibility to NAFLD (Non Alcoholic Fatty Liver Disease) and T2DM (Type 2 Diabetes Mellitus). DNA was extracted from the white blood cells of the subjects, and the gene polymorphism was determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In this study, 72 patients with NAFLD, 71 healthy individuals as control, 80 patients with T2DM, and 77 healthy controls were enrolled in the study.
Results: A higher prevalence of insertion/insertion genotype was observed in T2DM patients compared to the controls (p- value˂ 0.05). But, there was no difference in genotype distribution between NAFLD patients and controls (p-value> 0.05). NAFLD patients with D/D, D/I genotype had higher triglyceride, ALT, and AST levels; however, their HDL levels were lower than healthy controls. Patients with T2DM with D/D or D/I genotype also had significantly higher fasting serum glucose (FSG). While we found an association between the 45bp I/D polymorphism in 3ʹUTR of UCP2 and T2DM, no any correlation between this polymorphism and NAFLD was identified.
Loading...
Posted 08 Dec, 2020
On 13 Mar, 2021
Received 17 Feb, 2021
Invitations sent on 09 Jan, 2021
On 09 Jan, 2021
On 26 Nov, 2020
On 26 Nov, 2020
On 26 Nov, 2020
On 01 Nov, 2020
Received 08 Oct, 2020
On 28 Sep, 2020
Received 26 Sep, 2020
Invitations sent on 25 Sep, 2020
On 25 Sep, 2020
On 21 Sep, 2020
On 20 Sep, 2020
On 20 Sep, 2020
On 27 Jul, 2020
Received 21 Jul, 2020
Received 15 Jul, 2020
On 11 Jul, 2020
On 09 Jul, 2020
Invitations sent on 09 Jul, 2020
On 09 Jul, 2020
On 07 Jul, 2020
On 07 Jul, 2020
On 05 Jul, 2020
Posted 08 Dec, 2020
On 13 Mar, 2021
Received 17 Feb, 2021
Invitations sent on 09 Jan, 2021
On 09 Jan, 2021
On 26 Nov, 2020
On 26 Nov, 2020
On 26 Nov, 2020
On 01 Nov, 2020
Received 08 Oct, 2020
On 28 Sep, 2020
Received 26 Sep, 2020
Invitations sent on 25 Sep, 2020
On 25 Sep, 2020
On 21 Sep, 2020
On 20 Sep, 2020
On 20 Sep, 2020
On 27 Jul, 2020
Received 21 Jul, 2020
Received 15 Jul, 2020
On 11 Jul, 2020
On 09 Jul, 2020
Invitations sent on 09 Jul, 2020
On 09 Jul, 2020
On 07 Jul, 2020
On 07 Jul, 2020
On 05 Jul, 2020
Objective: Uncoupling protein 2 (UCP2) plays a crucial role in energy homeostasis via regulation of insulin secretion, free fatty acid concentrations, and lipid metabolism. This study aimed to investigate the association of 45-bp ins/del polymorphism of UCP2 with susceptibility to NAFLD (Non Alcoholic Fatty Liver Disease) and T2DM (Type 2 Diabetes Mellitus). DNA was extracted from the white blood cells of the subjects, and the gene polymorphism was determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In this study, 72 patients with NAFLD, 71 healthy individuals as control, 80 patients with T2DM, and 77 healthy controls were enrolled in the study.
Results: A higher prevalence of insertion/insertion genotype was observed in T2DM patients compared to the controls (p- value˂ 0.05). But, there was no difference in genotype distribution between NAFLD patients and controls (p-value> 0.05). NAFLD patients with D/D, D/I genotype had higher triglyceride, ALT, and AST levels; however, their HDL levels were lower than healthy controls. Patients with T2DM with D/D or D/I genotype also had significantly higher fasting serum glucose (FSG). While we found an association between the 45bp I/D polymorphism in 3ʹUTR of UCP2 and T2DM, no any correlation between this polymorphism and NAFLD was identified.
Loading...